SSX1 and prostate cancer: In prostate cancer, for example, it has been observed that SSX1 expression is restricted to metastatic lesions in prostate cancer, with increased SSX1 expression observed in patients with advanced disease compared to healthy donors and patients with early-stage disease [81].